Agilent “Dialogues in CDx” Podcast Series
Agilent “Dialogues in CDx” Podcast Series
Podcast Description
Tune into candid conversations among professionals in companion diagnostics, an important field in the world of precision medicine. Blending expertise with real-world experience across multiple disciplines, this series aims to illuminate the challenges, approaches, and latest perspectives in companion diagnostics through thoughtful and educational dialogue.
Podcast Insights
Content Themes
The podcast focuses on companion diagnostics in precision medicine, with specific episodes addressing topics such as the complexity of PD-L1 scoring algorithms, the PD-L1 testing journey, and collaborative approaches between pathologists and oncologists. Examples include discussions on diagnostic cutoffs and the importance of efficient testing workflows.
Tune into candid conversations among professionals in companion diagnostics, an important field in the world of precision medicine. Blending expertise with real-world experience across multiple disciplines, this series aims to illuminate the challenges, approaches, and latest perspectives in companion diagnostics through thoughtful and educational dialogue.
In the eighth episode of Agilent’s Dialogues in CDx, our guests from episode 7 continue the conversation on head and neck cancers with a more forward‑looking perspective. Building on the discussion of current practice, this episode explores what lies ahead—from emerging biomarkers and AI‑enabled pathology to the challenges and opportunities shaping the future of precision care in HNSCC.
Professor Cécile Badoual is a pathologist and Head ofthe Department of Medical Biology and Pathology at Gustave Roussy in Paris. An expert in head and neck cancers, her research focuses on the tumor microenvironment of HPV‑associated cancers. Beyond her current roles, she has held numerous senior academic and institutional leadership positions, and her career has been recognized with several prestigious honors for her contributions to pathology and translational cancer research.
Our second guest, Dr. Marc Oliva, is a medical oncologist and clinician‑scientist with a focus on head and neck malignancies and early drug development. He trained at Princess Margaret Cancer Centre in Toronto and is currently a full consultant at the Catalan Institute of Oncology in Barcelona. Dr. Marc Oliva has an established record of peer‑reviewed scientific publications and is actively engaged in the scientific publishing process as an editor and regular reviewer for leading international oncology and immunology journals.
This podcast series is part of the educational resources supporting the PD-L1 IHC 22C3 pharmDx assay.
For access to all episodes plus a wealth of additional PD-L1 education for pathologists, explore Agilent's CDx Digital Education Portaltoday.
D0147438_1.00
Disclaimer
This podcast’s information is provided for general reference and was obtained from publicly accessible sources. The Podcast Collaborative neither produces nor verifies the content, accuracy, or suitability of this podcast. Views and opinions belong solely to the podcast creators and guests.
For a complete disclaimer, please see our Full Disclaimer on the archive page. The Podcast Collaborative bears no responsibility for the podcast’s themes, language, or overall content. Listener discretion is advised. Read our Terms of Use and Privacy Policy for more details.